加味脑泰方通过SIRT1途径减轻脑缺血再灌注损伤
DOI:
作者:
作者单位:

(1.河南中医药大学第三附属医院脑病科,河南省郑州市 450000;2.郑州大学附属肿瘤医院中西医结合科,河南省郑州市 450003)

作者简介:

岳姣姣,硕士研究生,主治医师,研究方向为中医药防治脑血管病的临床研究,E-mail为qinghepeng30@163.com。通信作者李华华,硕士研究生,主治医师,研究方向为中西医结合治疗。

通讯作者:

基金项目:

河南省中医药科学研究专项课题(20-21ZY2219)


Modified Naotaifang attenuates cerebral ischemia-reperfusion injury by SIRT1 pathway
Author:
Affiliation:

1.Department of Brain Diseases, the Third Affiliated Hospital of Henan University of Traditional Chinese Medicine, Zhengzhou, Henan 450000, China;2.Department of Integrated Traditional Chinese and Western Medicine, Cancer Hospital Affiliated to Zhengzhou University, Zhengzhou, Henan 450003, China)

Fund Project:

  • 摘要
  • |
  • 图/表
  • |
  • 访问统计
  • |
  • 参考文献
  • |
  • 相似文献
  • |
  • 引证文献
  • |
  • 资源附件
    摘要:

    目的 研究加味脑泰方通过沉默信息调节蛋白1(SIRT1)途径减轻大鼠脑缺血再灌注损伤的作用及机制。方法 雄性SD大鼠随机分为对照组、模型组、加味脑泰方(JWF)组、JWF+EX527组,采用线栓法建立脑缺血再灌注损伤模型,JWF组给予加味脑泰方灌胃干预14天,JWF+EX527组给予加味脑泰方灌胃及SIRT1拮抗剂EX527腹腔注射干预14天,比较四组大鼠神经功能评分、炎症因子白细胞介素1β(IL-1β)、白细胞介素6(IL-6)、肿瘤坏死因子α(TNF-α)水平及B淋巴细胞瘤2(Bcl-2)、Bcl-2相关X蛋白(Bax)、SIRT1、核因子κB(NF-κB)、叉头框蛋白(FoxO1)表达量的差异。结果 与对照组比较,模型组大鼠神经功能评分、血清及脑组织中IL-1β、IL-6和TNF-α水平、脑组织中Bax、NF-κB和FoxO1表达量均明显增加,脑组织中Bcl-2、SIRT1表达量均减少(P<0.05);与模型组比较,JWF组大鼠神经功能评分、血清及脑组织中IL-1β、IL-6和TNF-α水平、脑组织中Bax、NF-κB和FoxO1表达量均明显减少,脑组织中Bcl-2、SIRT1表达量均明显增加(P<0.05);与JWF组比较,JWF+EX527组大鼠神经功能评分、血清及脑组织中IL-1β、IL-6和TNF-α水平、脑组织中Bax、NF-κB和FoxO1表达量均明显增加,脑组织中Bcl-2、SIRT1表达量均明显减少(P<0.05)。结论 加味脑泰方能够减轻大鼠脑缺血再灌注损伤,其可能的机制为激活SIRT1并抑制NF-κB介导的炎症反应以及FoxO1介导的细胞凋亡。

    Abstract:

    Aim To study the effect and mechanism of modified Naotaifang on cerebral ischemia-reperfusion injury of rats by activating SIRT1. Methods Male SD rats were randomly divided into control group, model group, JWF group and JWF+EX527 group. The model of cerebral ischemia-reperfusion injury was established by suture embolization.JWF group was given gavage of modified naotaifang for 14 days, JWF+EX527 group was given gavage of modified naotaifang and intraperitoneal injection of EX527 for 14 days. The differentces of neural function scores, inflammatory factor interleukin-1β(IL-1β), interleukin-6(IL-6), tumor necrosis factor-α(TNF-α), the expression of Bcl-2, Bax, silent information regulator 1 (SIRT1), nuclear factor-κB(NF-κB) and forkhead box O1(FoxO1) among the four groups were compared. Results Compared with the control group, the neural function scores, the levels of IL-1β, IL-6, TNF-α in serum and brain tissues, the expression of Bax, NF-κB, FoxO1 in brain tissues increased significantly, and the expression of Bcl-2, SIRT1 in brain tissues reduced significantly in the model group(P<0.05). Compared with the model group, the neural function scores, the levels of IL-1β, IL-6, TNF-α in serum and brain tissues, the expression of Bax, NF-κB, FoxO1 in brain tissues deceased significantly, and the expression of Bcl-2, SIRT1 in brain tissues increased significantly in JWF group(P<0.05). Compared with JWF group, the neural function scores, the levels of IL-1β, IL-6, TNF-α in serum and brain tissues, the expression of Bax, NF-κB, FoxO1 in brain tissues increased significantly, and the expression of Bcl-2, SIRT1 in brain tissues reduced significantly in JWF+EX527 group(P<0.05). Conclusion Modified Naotaifang can reduce the cerebral ischemia-reperfusion injury, and activating SIRT1 and then inhibiting NF-κB-mediated inflammatory response, FoxO1-mediated apoptosis was the possible mechanism.

    参考文献
    相似文献
    引证文献
引用本文

岳姣姣,李华华.加味脑泰方通过SIRT1途径减轻脑缺血再灌注损伤[J].中国动脉硬化杂志,2021,29(6):494~498.

复制
分享
文章指标
  • 点击次数:
  • 下载次数:
历史
  • 收稿日期:2020-06-15
  • 最后修改日期:2020-07-16
  • 录用日期:
  • 在线发布日期: 2021-06-11